Instil Bio (TIL) Accumulated Expenses (2020 - 2026)
Instil Bio (TIL) posted quarterly Accumulated Expenses of $3.9 million for Q1 2026, down 43.4% year-over-year from $6.9 million in Q1 2025, and down 3.3% quarter-over-quarter from $4.1 million in Q4 2025.
Instil Bio (TIL) Accumulated Expenses (2020 - 2026) Analysis & Trends
Instil Bio's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 43.4% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 43.4% YoY), while the FY2025 annual figure was $4.1 million, down 43.84% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $3.9 million, down from $4.1 million in the prior quarter.
- The five-year high for Accumulated Expenses was $37.2 million in Q2 2022, with the low at $3.9 million in Q1 2026.
- The 5-year median for Accumulated Expenses is $10.1 million (2024), against an average of $15.5 million.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses soared 131.35% in 2022, then tumbled 68.91% in 2023.
- Instil Bio's Accumulated Expenses stood at $30.1 million in 2022, then sank by 68.91% to $9.3 million in 2023, then declined by 22.57% to $7.2 million in 2024, then plunged by 43.84% to $4.1 million in 2025, then slipped by 3.3% to $3.9 million in 2026.
- Business Quant data shows TIL's Accumulated Expenses at $3.9 million in Q1 2026, $4.1 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.51 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 13.33 Mn |
| Mar 31, 2025 | 6.94 Mn |
| Dec 31, 2024 | 7.24 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 9.07 Mn |
| Mar 31, 2024 | 10.13 Mn |
| Dec 31, 2023 | 9.35 Mn |
| Sep 30, 2023 | 11.82 Mn |
| Jun 30, 2023 | 16.10 Mn |
| Mar 31, 2023 | 25.22 Mn |
| Dec 31, 2022 | 30.07 Mn |
| Sep 30, 2022 | 36.36 Mn |
| Jun 30, 2022 | 37.17 Mn |
| Mar 31, 2022 | 28.20 Mn |
| Dec 31, 2021 | 34.45 Mn |
| Sep 30, 2021 | 25.30 Mn |